Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides … Read more
Krishna Institute of Medical Sciences Limited (KIMS) - Net Assets
Latest net assets as of September 2025: ₹25.76 Billion INR
Based on the latest financial reports, Krishna Institute of Medical Sciences Limited (KIMS) has net assets worth ₹25.76 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹66.25 Billion) and total liabilities (₹40.49 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹25.76 Billion |
| % of Total Assets | 38.88% |
| Annual Growth Rate | 23.49% |
| 5-Year Change | 176.06% |
| 10-Year Change | 795.17% |
| Growth Volatility | 50.21 |
Krishna Institute of Medical Sciences Limited - Net Assets Trend (2013–2025)
This chart illustrates how Krishna Institute of Medical Sciences Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Krishna Institute of Medical Sciences Limited (2013–2025)
The table below shows the annual net assets of Krishna Institute of Medical Sciences Limited from 2013 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹24.19 Billion | +15.55% |
| 2024-03-31 | ₹20.93 Billion | +8.01% |
| 2023-03-31 | ₹19.38 Billion | +37.38% |
| 2022-03-31 | ₹14.11 Billion | +61.00% |
| 2021-03-31 | ₹8.76 Billion | +43.30% |
| 2020-03-31 | ₹6.11 Billion | +7.85% |
| 2019-03-31 | ₹5.67 Billion | +510.14% |
| 2018-03-31 | ₹-1.38 Billion | -141.41% |
| 2017-03-31 | ₹3.34 Billion | +23.55% |
| 2016-03-31 | ₹2.70 Billion | +10.60% |
| 2015-03-31 | ₹2.44 Billion | +21.16% |
| 2014-03-31 | ₹2.02 Billion | +4.84% |
| 2013-03-31 | ₹1.92 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Krishna Institute of Medical Sciences Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 911.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹10.35 Billion | 48.42% |
| Common Stock | ₹800.00 Million | 3.74% |
| Other Comprehensive Income | ₹-114.00 Million | -0.53% |
| Other Components | ₹10.34 Billion | 48.37% |
| Total Equity | ₹21.38 Billion | 100.00% |
Krishna Institute of Medical Sciences Limited Competitors by Market Cap
The table below lists competitors of Krishna Institute of Medical Sciences Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CJ Corp 4P Pref
KO:00104K
|
$1.80 Billion |
|
DMG Mori Co. Ltd
F:0MO
|
$1.81 Billion |
|
Giantec Semiconductor Corp
SHG:688123
|
$1.81 Billion |
|
Caris Life Sciences, Inc. Common Stock
NASDAQ:CAI
|
$1.81 Billion |
|
Business intelligence of Oriental Nations Corp Ltd
SHE:300166
|
$1.80 Billion |
|
CHINA CONCH VENT. HD -01
F:68C
|
$1.80 Billion |
|
Nicolet Bankshares Inc.
NYSE:NIC
|
$1.80 Billion |
|
Jollibee Foods Corporation
PINK:JBFCF
|
$1.80 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Krishna Institute of Medical Sciences Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 18,283,570,000 to 21,378,000,000, a change of 3,094,430,000 (16.9%).
- Net income of 3,845,000,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 17,597,290,000.
- Other factors increased equity by 16,846,720,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹3.85 Billion | +17.99% |
| Other Comprehensive Income | ₹-17.60 Billion | -82.31% |
| Other Changes | ₹16.85 Billion | +78.8% |
| Total Change | ₹- | 16.92% |
Book Value vs Market Value Analysis
This analysis compares Krishna Institute of Medical Sciences Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.58x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 122.54x to 12.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-03-31 | ₹5.48 | ₹672.00 | x |
| 2014-03-31 | ₹5.62 | ₹672.00 | x |
| 2015-03-31 | ₹6.78 | ₹672.00 | x |
| 2016-03-31 | ₹7.48 | ₹672.00 | x |
| 2017-03-31 | ₹9.24 | ₹672.00 | x |
| 2018-03-31 | ₹-4.18 | ₹672.00 | x |
| 2019-03-31 | ₹13.51 | ₹672.00 | x |
| 2020-03-31 | ₹15.93 | ₹672.00 | x |
| 2021-03-31 | ₹22.69 | ₹672.00 | x |
| 2022-03-31 | ₹34.93 | ₹672.00 | x |
| 2023-03-31 | ₹41.72 | ₹672.00 | x |
| 2024-03-31 | ₹45.69 | ₹672.00 | x |
| 2025-03-31 | ₹53.43 | ₹672.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Krishna Institute of Medical Sciences Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.99%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.67%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 2.68x
- Recent ROE (17.99%) is above the historical average (11.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 9.82% | 6.42% | 0.52x | 2.94x | ₹-3.52 Million |
| 2014 | 3.54% | 1.95% | 0.56x | 3.24x | ₹-126.85 Million |
| 2015 | 2.35% | 1.33% | 0.64x | 2.76x | ₹-182.37 Million |
| 2016 | 10.11% | 5.20% | 0.77x | 2.53x | ₹2.79 Million |
| 2017 | 9.97% | 5.74% | 0.73x | 2.37x | ₹-872.00K |
| 2018 | 0.00% | -7.14% | 0.69x | 0.00x | ₹-315.11 Million |
| 2019 | -8.84% | -5.20% | 0.82x | 2.07x | ₹-1.02 Billion |
| 2020 | 19.93% | 10.62% | 0.94x | 2.00x | ₹593.71 Million |
| 2021 | 23.30% | 15.13% | 0.93x | 1.66x | ₹1.15 Billion |
| 2022 | 23.98% | 20.15% | 0.87x | 1.37x | ₹1.94 Billion |
| 2023 | 20.14% | 15.30% | 0.75x | 1.76x | ₹1.69 Billion |
| 2024 | 16.96% | 12.42% | 0.65x | 2.11x | ₹1.27 Billion |
| 2025 | 17.99% | 12.67% | 0.53x | 2.68x | ₹1.71 Billion |
Industry Comparison
This section compares Krishna Institute of Medical Sciences Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $12,536,726,583
- Average return on equity (ROE) among peers: 4.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Krishna Institute of Medical Sciences Limited (KIMS) | ₹25.76 Billion | 9.82% | 1.57x | $1.80 Billion |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $48.02 Billion | 3.13% | 1.38x | $8.68 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $8.87 Billion | 5.90% | 0.85x | $1.46 Billion |
| Fortis Healthcare Limited (FORTIS) | $40.85 Billion | 1.77% | 2.04x | $4.64 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.18 Billion | 21.86% | 0.58x | $38.63 Million |
| Healthcare Global Enterprises Limited (HCG) | $2.96 Billion | -3.55% | 1.40x | $318.06 Million |
| Indraprastha Medical Corporation Limited (INDRAMEDCO) | $1.59 Billion | 16.95% | 1.52x | $192.52 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $2.37 Billion | 12.52% | 1.55x | $351.75 Million |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $493.84 Million | -4.01% | 0.14x | $7.96 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $5.49 Billion | -11.78% | 1.33x | $7.97 Billion |